Why Aegerion Pharmaceuticals, Bank of America and Three Other Stocks are in Spotlight Today?
Markets opened higher on Wednesday as investors await the announcement regarding interest rate hike from the Federal Reserve today.
Posts Tagged ‘NASDAQ:AEGR’
Sarissa Capital Management and Aegerion Pharmaceuticals, Inc. (AEGR) Amend Nomination Agreement
In a recent filing with the US Securities and Exchange Commission, Alex Denner's Sarissa Capital Management has reported entering into an amendment to the nomination agreement...
Pharmaceutical And LNG Stocks Are Driving The Market Higher Today
U.S. stocks look set to end today's trading session in green territory, having gone through a strong selloff last week.
These Four Stocks Are Leading Today’s Losers Pack for Various Reasons
Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red.
Aegerion Pharmaceuticals, Inc. (AEGR): Sarissa Capital Management Files Amended 13D
Sarissa Capital Management filed an amended 13D today regarding Aegerion Pharmaceuticals (NASDAQ:AEGR) disclosing the confidentiality agreement between the activist hedge fund...
One Fund is Buying This Biotech Stock Although It’s Losing Smart Money’s Support
Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company.
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler's Broadfin Capital has initiated a stake in ContraFect Corp (NASDAQ:CFRX) to the...
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector
At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with the Securities and Exchange...
Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors
Kevin Kotler's New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR).
Lumber Liquidators Holdings Inc (LL): Steve Cohen’s Point72 Seems To Love This Stock
Steve Cohen’s Point72 Asset Management disclosed today a huge increase in its stake in Lumber Liquidators Holdings Inc (NYSE:LL). The funds affiliated with Mr.
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.
Aegerion Pharmaceuticals, Inc. (AEGR): Steve Cohen’s Point72 Asset Management Goes Big
Life science is turning out to be an industry sector that most hedgies are convinced will outperform in the near future.
Aegerion Pharmaceuticals, Inc. (AEGR) & The GEO Group Inc (GEO): Scopia Capital Bets On Biotech Recovery, Gets Out Of Real Estate
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals...
Two Healthcare Stocks That Insiders Are Buying
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked.
Billionaire Mark Kingdon’s Top Stock Picks: HCA Holdings, Delta Air Lines & Others
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Stewart Enterprises, Inc. (STEI), Smithfield Foods, Inc. (SFD), The Fresh Market Inc (TFM) & More: Are These Stocks Worth Buying?
We will take a quick look at four stocks that have had substantial rises in price so far today. The four stocks we will review are: Stewart Enterprises, Inc.
Hedge Fund Resource Center
